Figure 2From: Loss-of-heterozygosity on chromosome 19q in early-stage serous ovarian cancer is associated with recurrent disease Differences in frequency of tumors with aberrations between tumor with and without recurrence across the genome. Gains (total copy number 3 and higher) (A). Total copy number 1 (B) and LOH irrespective of total copy number (C).Back to article page